Clinical Trial Update: MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

View source ↗

Summary

This ClinicalTrials.gov entry notes completion and posting of results for a trial evaluating rituximab in combination with CHOP or CHOP-like chemotherapy in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• MabThera (rituximab)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Status: COMPLETED | Results posted: 2016-02-22